A functional polymorphism in microRNA-196a2 is associated with increased susceptibility to non-Hodgkin lymphoma

Tumor Biology

Volumn 36, Issue 5, 2015, Pages 3279-3284

  Li, Tao ^a   Niu, Lijuan ^b   Wu, Lili ^a   Gao, Xia ^a   Li, Man ^a   Liu, Wenxuan ^a   Yang, Lei ^a   Liu, Dianwu ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Department of Hand Surgery   (China)

Author keywords

microRNA; miRNA 196a2; Non Hodgkin lymphoma; rs11614913 polymorphism; Susceptibility

Indexed keywords

MICRORNA; MICRORNA 196A2; UNCLASSIFIED DRUG; MIRN196 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; BONE MARROW; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TUMOR INVASION; VERY ELDERLY; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; YOUNG ADULT;

EID: 84929956316     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2957-y     Document Type: Article

References (30)

1. Ekström-Smedby K. Epidemiology and etiology of non-Hodgkin lymphoma-a review. Acta Oncol. 2006;45:258–71.
2. Cox B, Liu CW, Sneyd MJ, Cameron CM. Epidemic of non-Hodgkin lymphoma in New Zealand remains unexplained. J Cancer Epidemiol. 2014. doi:10.1155/2014/315378.
3. Liu J, Song B, Fan TY, Huang CS, Xie C, Li J, et al. Pathological and clinical characteristics of 1,248 non-Hodgkin’s lymphomas from a regional cancer hospital in Shandong. China Asian Pac J Cancer Prev. 2011;12:3055–61.
4. Huang YW, Zhang MB, Xu X, Xu XH, Zhou Q, Jian L. Socioeconomic inequality in the use of rituximab therapy among non-Hodgkin lymphoma patients in Chinese public hospitals. Asia Pac J Public Health. 2014;26:203–14.
5. Shankland KR, Armitage JO, Hancock BW. Non-Hodgkin lymphoma. Lancet. 2012;380:848–57.
6. Yang B, Liu C, Diao LP, Wang CJ, Guo ZJ. A polymorphism at the microRNA binding site in the 3’untranslated region of C14orf101 is associated with non-Hodgkin lymphoma overall survival. Cancer Genet. 2014;207:141–6.
7. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97.
8. Wienholds E, Plasterk RH. MicroRNA function in animal development. FEBS Lett. 2005;579:5911–22.
9. Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, et al. Phylogenetic shadowing and computational identification of human microRNA genes. Cell. 2005;120:21–4.
10. Shastry BS. SNPs: impact on gene function and phenotype. Methods Mol Biol. 2009;578:3–22.
11. Jedlinski DJ, Gabrovska PN, Weinstein SR, Smith RA, Griffiths LR. Single nucleotide polymorphism in hsa-mir-196a-2 and breast cancer risk: a case control study. Twin Res Hum Genet. 2011;14:417–21.
12. Zhu LJ, Chu HY, Gu DY, Ma L, Shi DN, Zhong DY, et al. A functional polymorphism in miRNA-196a2 is associated with colorectal cancer risk in a Chinese population. DNA Cell Biol. 2012;31:350–4.
13. Lv M, Dong W, Li L, Zhang L, Su X, Wang L, et al. Association between genetic variants in pre-miRNA and colorectal cancer risk in a Chinese population. J Cancer Res Clin Oncol. 2013;139:1405–10.
14. Akkız H, Bayram S, Bekar A, Akgöllü E, Ulger Y. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case–control study. J Viral Hepat. 2011;18:e399–407.
15. Linhares JJ, Azevedo Jr M, Siufi AA, de Carvalho CV, WolgienMdel C, Noronha EC, et al. Evaluation of single nucleotide polymorphisms in microRNAs (hsa-miR-196a2 rs11614913 C/T) from Brazilian women with breast cancer. BMC Med Genet. 2012. doi:10.1186/1471-2350-13-119.
16. Kim MJ, Yoo SS, Choi YY, Park JY. A functional polymorphism in the pre-microRNA-196a2 and the risk of lung cancer in a Korean population. Lung Cancer. 2010;69:127–9.
17. Peng S, Kuang Z, Sheng C, Zhang Y, Xu H, Cheng Q. Association of microRNA-196a-2 gene polymorphism with gastric cancer risk in a Chinese population. Dig Dis Sci. 2010;55:2288–93.
18. Srivastava K, Srivastava A, Mittal B. Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population. J Hum Genet. 2010;55:495–9.
19. Wang K, Guo H, Hu H, Xiong G, Guan X, Li J, et al. A functional variation in pre-microRNA-196a is associated with susceptibility of esophageal squamous cell carcinoma risk in Chinese Han. Biomarkers. 2010;15:614–8.
20. Tong N, Xu B, Shi D, Du M, Li X, Sheng X, et al. Hsa-miR-196a2 polymorphism increases the risk of acute lymphoblastic leukemia in Chinese children. Mutat Res. 2014;759:16–21.
21. Sabattini E, Bacci F, Sagramoso C, Pileri SA. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica. 2010;102:83–7.
22. Hu ZB, Chen JP, Tian T, Zhou XY, Gu HY, Xu L, et al. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest. 2008;118:2600–8.
23. Dikeakos P, Theodoropoulos G, Rizos S, Tzanakis N, Zografos G, Gazouli M. Association of the miR-146aC>G, miR-149T>C, and miR-196a2T>C polymorphisms with gastric cancer risk and survival in the Greek population. Mol Biol Rep. 2014;41:1075–80.
24. Wang PY, Gao ZH, Jiang ZH, Li XX, Jiang BF, Xie SY. The associations of single nucleotide polymorphisms in miR-146a, miR-196a and miR-499 with breast cancer susceptibility. PLoS One. 2013;8:e70656.
25. Chen H, Sun LY, Chen LL, Zheng HQ, Zhang QF. A variant in microRNA-196a2 is not associated with susceptibility to and progression of colorectal cancer in Chinese. Intern Med J. 2012;42:e115–9.
26. Kang ZJ, Li YH, He XK, Jiu T, Wei JX, Tian FY, et al. Quantitative assessment of the association between miR-196a2 rs11614913 polymorphism and cancer risk: evidence based on 45,816 subjects. Tumor Biol. 2014;35:6271–82.
27. Diao LP, Ma H, Wei GC, Li T, Liu HS, Liu LH, et al. Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin’s lymphoma. Int J Cancer. 2012;131:1095–103.
28. Yu ZF, Kim J, He L, Creighton CJ, Gunaratne PH, Hawkins SM, et al. Functional analysis of miR-34c as a putative tumor suppressor in high grade serous ovarian cancer. Biol Reprod. 2014. doi:10.1095/biolreprod.114.121988.
29. Li XD, Li ZG, Song XX, Liu CF. A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis. Pathology. 2010;42:669–73.
30. Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, Slack F, et al. microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res. 2009;69:5970–7.